Sale!

CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CDKN1B gene, which are linked to Multiple Endocrine Neoplasia Type 4 (MEN4). MEN4 is a rare hereditary condition characterized by the development of tumors or overgrowth in multiple endocrine glands, including the parathyroid, adrenal, and pituitary glands. This condition can lead to various health issues, including hormonal imbalances and increased risk of certain cancers.

The test is crucial for individuals with a family history of MEN4 or those presenting symptoms associated with the condition, as early detection can significantly influence management and treatment strategies. Conducted through a simple blood sample, the genetic analysis focuses on identifying mutations in the CDKN1B gene, which plays a pivotal role in cell cycle regulation. Identifying mutations in this gene can confirm a diagnosis of MEN4, enabling proactive health management and surveillance for affected individuals and their families.

The cost of the CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis and expert interpretation of results, ensuring patients and healthcare providers have the necessary information for informed decision-making regarding treatment and preventive measures.

Description

CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test

Test Name: CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CDKN1B Gene Multiple Endocrine Neoplasia Type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN1B Gene Multiple Endocrine Neoplasia Type 4 NGS Genetic DNA Test gene CDKN1B

Test Details: The CDKN1B gene is associated with multiple endocrine neoplasia type 4 (MEN4), which is a rare genetic disorder characterized by the development of tumors in multiple endocrine glands. The CDKN1B gene provides instructions for producing a protein called p27, which plays a role in controlling cell division and preventing the formation of tumors. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. In the context of MEN4, NGS genetic testing can identify mutations or variations in the CDKN1B gene that may be associated with the development of the disorder. NGS genetic testing for MEN4 can be useful in diagnosing individuals with suspected MEN4, as well as in identifying carriers of CDKN1B gene mutations within families. This information can help guide medical management and surveillance for individuals at risk of developing MEN4-related tumors. It is important to note that NGS genetic testing is typically performed by healthcare professionals with expertise in genetics, and the results should be interpreted in the context of the individual’s medical history and family history. Genetic counseling is often recommended before and after genetic testing to discuss the potential implications of the results and to provide support and guidance.

Test Name	CDKN1B Gene Multiple endocrine neoplasia type 4 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CDKN1B Gene Multiple endocrine neoplasia type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN1B Gene Multiple endocrine neoplasia type 4 NGS Genetic DNA Test gene CDKN1B
Test Details	The CDKN1B gene is associated with multiple endocrine neoplasia type 4 (MEN4), which is a rare genetic disorder characterized by the development of tumors in multiple endocrine glands. The CDKN1B gene provides instructions for producing a protein called p27, which plays a role in controlling cell division and preventing the formation of tumors. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. In the context of MEN4, NGS genetic testing can identify mutations or variations in the CDKN1B gene that may be associated with the development of the disorder. NGS genetic testing for MEN4 can be useful in diagnosing individuals with suspected MEN4, as well as in identifying carriers of CDKN1B gene mutations within families. This information can help guide medical management and surveillance for individuals at risk of developing MEN4-related tumors. It is important to note that NGS genetic testing is typically performed by healthcare professionals with expertise in genetics, and the results should be interpreted in the context of the individual’s medical history and family history. Genetic counseling is often recommended before and after genetic testing to discuss the potential implications of the results and to provide support and guidance.